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Abstract
Medulloblastoma (MB) is the most common brain cancer diagnosed among children. The cellular
pathways that regulate MB invasion in response to environmental cues remain incompletely
understood. Herein, we examine the migratory response of human MB-derived Daoy cells to
different concentration profiles of Epidermal Growth Factor (EGF) using a microfluidic system.
Our findings provide the first quantitative evidence that EGF concentration gradients modulate the
chemotaxis of MB-derived cells in a dose-dependent manner via the EGF receptor (EGF-R). Data
illustrates that higher concentration gradients caused increased number of cells to migrate. In
addition, our results show that EGF-induced receptor phosphorylation triggered the downstream
activation of phosphoinositide-3 kinase (PI3K)/Akt pathway, while its downstream activation was
inhibited by Tarceva (an EGF-R inhibitor), and Wortmannin (a PI3K inhibitor). The treatment
with inhibitors also severely reduced the number of MB-derived cells that migrated towards
increasing EGF concentration gradients. Our results provide evidence to bolster the development
of anti-migratory therapies as viable strategies to impede EGF-stimulated MB dispersal.
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INTRODUCTION
Medulloblastoma (MB) is the most common malignant brain tumor in children, with a 60%
survival rate 5 years after diagnosis.9,31 The disease is difficult to treat via surgery because
of high tumor invasiveness and tumor re-occurrence following resection and/or irradiation.12
Despite the well-known metastatic potential of these pediatric tumors, the chemotactic
migration of MB remains surprisingly understudied. The directed migration of brain tumor-
derived cells is highly complex, involving interactions with extracellular matrix (ECM) and
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chemoattractants that either diffuse from blood vessels or are produced by neighboring
cells.6,24,33 The migration of cells derived from glioma, the most common malignant tumor
in adult brain, has been extensively studied and shown to be highly dosage-dependent to
signaling from three principal growth factors: Hepatocyte Growth Factor (HGF), Platelet-
Derived Growth Factor (PDGF), and Epidermal Growth Factor (EGF).3 By contrast, MB
migration has been shown to depend on c-MET, the HGF receptor,13 as well as the PDGF-
receptor B (PDGFR-B), but EGF-R-dependent migration in MB has only recently been
examined.
EGF-R, also known as ErbB1 or HER1, is a primary oncogene19,34,40 whose over-
expression is recognized as a significant step in the progression and pathology of brain
tumors. Multiple mechanisms are involved in EGF-R activation, including expression of
EGF and EGF-R by neighboring tumor or stromal cells, enhanced cell sensitivity for EGF-
like ligands, and constitutively active EGF-R mutations that lead to ligand-independent
activation of the receptor (reviewed in Hirata et al.16). The role of EGF-R in MB is highly
significant, as the receptor is known to be expressed in the cerebellar granule neuron
precursor cells (GNPCs)35 whose dysregulation is suspected in MB tumorigenesis.37 One
quantitative study has illustrated that engineered over-expression of the EGF-R homolog,
ErbB2, increased the migration of MB in vitro.15 Another study has demonstrated that
transactivation of EGF-R via PDGFR-B activity was able to guide MB migration in vivo.2
Further, EGF-mediated migration has been shown to be concentration gradient-dependent,
as breast cancer cells,32 fibroblast cells21 and glioma cells1 responded to increasing
gradients of EGF via higher motility in vitro.
In the present work, we utilize a microfluidic system20 to examine the chemotactic
migration of MB-derived cells towards EGF. We examine MB chemotactic dependency on
EGF-R phosphorylation, consequent motility in response to a range of EGF concentration
profiles, as well as activation of downstream phosphoinositide-3 kinase (PI3K)/Akt. Our
results illustrate that EGF-initiated MB migration relies on the PI3K/Akt signaling pathway,
and is ligand-dependent despite constitutive, basal EGF-R signaling. In addition, we
demonstrate that larger concentration gradients of EGF stimulate increased numbers of MB
cells to become motile. Our results comprehensively point to the significance of EGF-
mediated invasion of MB, and highlight how targeting of the molecular triggers that drive




The MB-derived Daoy cell line (#HTB-186, purchased from ATCC, Manassas, VA) was
established from a tumor biopsy of a 4-year-old boy. Cells were cultured with sterile Eagle
Minimum Essential Medium (EMEM) without phenol red (pH 7.1–7.4) (Mediatech Inc.,
Herndon, VA), supplemented with 2% L-glutamine (Mediatech Inc., Herndon, VA), 1%
Penicillin–Streptomycin–Amphotericin B—100× solution (Mediatech Inc., Herndon, VA),
and 10% fetal bovine serum (FBS) (Gemini Bio-Products, West Sacramento, CA). The cells
were grown onto sterile polystyrene tissue culture flasks (BD Biosciences, Franklin Lakes,
NJ) and incubated at 37 °C with 5% CO2.
Antibodies and Immunocytochemistry
Immunocytochemistry was performed as described previously.7 Briefly, Daoy cells grown
on coverslips were fixed with paraformaldehyde (Sigma, St. Louis, MO) and labeled with
mouse anti-phosphorylated-EGF-R (1:500) (Meridian Life Sciences, Saco, ME), mouse anti-
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internal-EGF-R (1:500)—recognizing an internal epitope (Meridian Life Sciences, Saco,
ME), rabbit anti-phosphorylated-Akt (1:200) (Cell Signaling, Danvers, MA), rabbit anti-
phosphorylated-ERK-1/ERK-2 (1:200) (Cell Signaling, Danvers, MA), anti-mouse and anti-
rabbit AlexaFluor® 488 or 594 antibodies (Invitrogen Molecular Probes, Eugene, OR).
Transferrin AlexaFluor® 594 conjugate (Tf) and Cholera toxin subunit B AlexaFluor® 594
(CT-B) (both from Invitrogen Molecular Probes, Eugene, OR) were used to label the
clathrin-mediated and clathrin-independent endocytic pathway, respectively. A 20 μg/mL
solution of Tf or a 10 μg/mL solution of CT-B were applied and incubated with Daoy cells
for 1 h at 37 °C. After antibody labeling, the cells were fixed with paraformaldehyde and
mounted in glycerol. Each experiment was performed at least three times.
Stimulation and Inhibition of EGF-R and Akt
The stimulation of signaling pathways was adapted from the literature.11 Briefly, monolayer
cultures were separately incubated with 10, 100, and 1000 ng/mL EGF or EGF-Alexa 488
(Invitrogen Molecular Probes, Eugene, OR) for 20 min or 1 h at 37 °C. The active EGF-R
was inhibited by incubating stimulated Daoy cells for 30 min or 1 h at 37 °C with 1 μM
Tarceva,17 kindly provided by Dr. Eric Holland, Memorial Sloan-Kettering Cancer Center,
New York, NY). In a similar manner, the active PI3K was inhibited by incubating
stimulated Daoy cells for 1 h at 37 °C with 0.5 μM Wortmannin (EMD-Calbiochem,
Gibbstown, NJ). All cell samples were fixed and stained immediately following
experimental protocols.
Confocal Microscopy and Image Analysis
Confocal laser scanning microscopy imaging was performed using a Leica TCS SP2
instrument with a 63× oil immersion objective (NA 1.4). Identical imaging conditions were
used for each set of experiments. Analysis of the confocal images was performed using
Matlab software (version 7.7.0.471). Fluorescence normalization was performed in order to
measure whether the baseline of EGF-R, pEGF-R, pAkt, and pERK increased or decreased
overall per cell. Basal gray levels were normalized per cell area and set to 1 in order to
identify a control baseline per cell. A sample exceeding n = 10 was used for each
experiment. Co-localization was determined using pixel area and defined as the 90–100%
overlapping of data points. Co-localization with TF indicates markers coincide with clathrin-
mediated endocytosis, while lack thereof with CT-B indicates no evidence for nonclathrin-
medicated endocytosis. Statistical significance was analyzed by performing Anova t-tests
with the InStat software (GraphPad Software Inc., La Jolla, CA).
Controlled Microenvironment
This study utilized our laboratory-developed μLane system, whose design and testing has
been previously described.20 The system was fabricated using contact photolithography,
elastomeric molding of polydimethylsiloxane (PDMS), and ozone bonding of PDMS to
glass microscope slides. The μLane relies on molecular diffusion to generate concentration
gradients and sustain steady-state over a period of 2–3 days. The system consists of a single,
closed microchannel that connects two fluidic reservoirs, called the sink and the source
chambers, as shown in Figs. 1a and 1b. The microchannel used in this study is 7000 μm in
length and 95 μm in hydraulic diameter, while the source and sink chambers contain a 9 and
170 μL volume, respectively.
Molecular transport within ECM of the μLane was validated experimentally and
computationally using Dextran (6 kDa; Invitrogen, Eugene, OR) as a model, based on
similar hydrodynamic, or Stokes radii, and molecular configurations to EGF.4,28
Experimental measurement of Dextran diffusion was performed as described in the
literature,18 by tracking the displacement of the fluorescently-labeled molecule. In order to
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determine the concentration distribution within our system, 40 μg/mL Dextran was mixed
with 2.5 mg/mL Growth Factor-Reduced Matrigel (BD Biosciences, San Jose, CA), used as
ECM, and loaded into the microchannel. The source and sink chambers were subsequently
filled with EMEM. Fluorescent Dextran diffusion within the microchannel was imaged at
different positions along the channel using time-lapse microscopy using the Nikon TE2000
inverted microscope with a 20× long working distance dry objective (NA 0.40/WD 3.0 mm)
and a cooled CCD camera (CoolSNAP EZ, Photometrics, Tucson, AZ). Images were
recorded every hour for 84 h using Nikon software (Nikon Instrument Element 2.30 with 6D
module, Morrell Instrument Company Inc., Melville, NY). The fluorescence intensity was
measured at all time-points using the Nikon software. Experimental measurement of
Dextran transport illustrated a transient evolution of a linear, steady-state concentration
gradient along the microchannel after t = 70 h, as shown in Fig. 1c.
Computational modeling of Dextran concentration profiles within the μLane system was
performed using Finite Element Modeling (FEMLab version 3.2, Comsol Inc. Burlington,
MA to model the one-dimensional diffusion equation:
(1)
where C (mg/mL) is the concentration, and D (m2/s) is diffusivity.21 FEM computation used
an initial reagent concentration in the source chamber and microchannel of 40 μg/mL in
order to match the experimental conditions, and an initial concentration in the sink chamber
of 0 μg/mL. Reported diffusivity values of Dextran10,23,30,38 were substituted into the model
in order to generate spatial concentration profiles within the microchannel that most
accurately modeled those measured experimentally. Computational predictions illustrated in
a linear, steady-state gradient along the 7-mm-long microchannel after t = 70 h (Fig. 1d).
Finite Element Modeling of the Dextran concentration profiles generated within the
microchannel and in the source and sink chambers, respectively, is shown in Fig. 1e. We
employed the same modeling to predict that EGF diffusion will achieve steady-state within t
= 70 h within the μLane design used in this study (Figs. 1c and 1d).
Cell Migration Experiments
EGF at different concentrations (10, 100, or 1000 ng/mL and 0 ng/mL for control) was
mixed with 2.5 mg/mL Growth Factor-Reduced Matrigel and loaded into the microchannel
and the source chamber via syringe. The μLane systems were placed in a micro-incubator
(Warner Instruments LLC, Hamden, CT) that was maintained at 37 °C and mounted on a
motorized stage of a Nikon TE2000 inverted microscope. No CO2 control was used in this
study. However, the pH-indicator medium used for each test did not indicate significant
changes in pH. MB cells at a cell density of 106/mL and in a solution of EMEM were added
into the sink reservoir. Cells were loaded such that they adhered evenly to the bottom of the
chamber and along its microchannel interface. Cell movement into the microchannel from
the sink chamber was monitored through light microscopy, using a 20× long working
distance dry objective and a cooled CCD camera. Experiments using long working distance
objectives verified that cells were migrating within the entire 3D ECM during testing, but
data captured via inverted scope can only measure those cells closest to the coverslip.
Images of cells moving from the sink chamber into the microchannel were recorded for 72 h
using Nikon software (Nikon Instrument Element 2.30 with 6D module, Morrell Instrument
Company Inc., Melville, NY). The total number of migrating cells into the microchannels
were counted, and the total distance migrated by each of those cells was measured using
Nikon software. Note that experiments utilized serum in order to better match the
conventional Boyden chamber assays used by previous work from our lab1,21 and others3
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that utilize the assays as benchmarks for migration. As demonstrated previously in the
literature,41 Boyden chamber experiments using serum-starved MB cells vs. non-serum
starved cells confirmed near identical chemotactic behaviors (data in Supplemental Fig. 1).
Migration experiments were performed using known inhibitors of EGF and PI3K pathways.
Cells were separately treated for 1 h with 1 μM Tarceva (EGF-R inhibitor), or with 0.5 μM
Wortmannin (PI3K inhibitor). Treated cells were loaded into the sink chamber of the μLane
and their migration imaged and analyzed as described before. Note that inhibitor
experiments were only performed using the gradients generated under experimental
conditions of 1000 ng/mL EGF. For all migration experiments, the data was plotted and
statistical significance was analyzed via Anova tests with InStat software (GraphPad
Software Inc., La Jolla, CA).
Lastly, recorded data for chemotactic migration was distinguished from chemokinetic
movement (i.e., non-directional) by relying on controls that filled the entire microsystem
(reservoirs and channel) with ECM to reveal minimal cell movement in the absence of
exogenous EGF. Further, changes in cell chemokinesis in the presence of different EGF
concentrations (10, 100, and 1000 ng/mL) were statistically insignificant from that of
control experiments as observed via measuring positional changes of cell centroids (n > 15)
during a 40-h test period.
Cell Cytoplasmic Extensions and Cell Shape Index
Cells were cultured within 2.5 mg/mL of Matrigel with or without 100 ng/mL EGF for up to
100 h. Images of the cells were recorded using the Nikon TE2000 and Nikon software. The
cytoplasmic extensions of cells were counted and their numbers were averaged at the focal
plane illustrating the maximum cell area. The average cell morphology was analyzed using
the cell shape index (CSI),36 as done previously by our group20:
(2)
where A represents the cell projected area, and P denotes the cell perimeter. Statistical
significance of data differences was analyzed via Student t-tests using InStat software.
RESULTS
Basal and Ligand-Activated EGF-R in MB
In order to examine EGF-induced migration of MB, we first investigated EGF-R activation,
inhibition, and localization. The total EGF-R population within the MB cells studied was
detected via an antibody that recognized the intracellular region of the receptor, iEGF-R.
Here, iEGF-R was labeled in non-stimulated cells (Fig. 2a), in cells stimulated with EGF
(Fig. 2b), and in cells where the effect of the stimulation was inhibited by using Tarceva
(Fig. 2c). Tarceva is a commercial compound known to inhibit EGF-R autophosphorylation
without affecting EGF-R expression or surface receptor density.14 No significant difference
in total intensity levels of EGF-R between stimulated and Tarceva-inhibited cells were
measured with respect to controls (Fig. 2d). Next, immunolabeling was performed with an
antibody that recognized phosphorylated EGF-R (pEGF-R). Results illustrated that MB-
derived cells exhibited basal levels of activated EGF-R (Fig. 2e). Interestingly, EGF
stimulation of MB increased cellular levels of pEGF-R (Fig. 2f) by 2.8 fold (Fig. 2h),
indicative of a ligand-dependent EGF-R response regardless of basal EGF-R signaling.
Treatment with Tarceva consistently abolished ligand-induced EGF-R phosphorylation (Fig.
2g), as levels of phosphorylated EGF-R were similar to those detected in non-stimulated
cells (Fig. 2h). Next, MB-derived cells were incubated with Transferrin (Tf), a marker of the
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clathrin-mediated endocytic pathway and Cholera Toxin Subunit-B (CT-B), a marker of the
clathrin-independent endocytic pathway, as done previously by our group.8 In MB-derived
cells, iEGF-R was seen to co-localize predominantly with Tf: 92 ± 3% (Figs. 2i1–3 and 2j),
but only 14 ± 4% with CT-B (Fig. 2j). We note that co-localization with TF indicates
markers coincide with clathrin-mediated endocytosis, while lack thereof with CT-B
indicates no evidence for non-clathrin-medicated endocytosis.25
EGF Induces Akt Phosphorylation in MB
The next set of experiments examined the role of PI3K/Akt and MAPK/ERK signaling in
the EGF-R-induced response of MB, as activation and cross-talk of these pathways
downstream of activated EGF-R is well-known in glioblastoma and breast cancer
migration.22,43 Levels of phosphorylated Akt (pAkt) in cells stimulated with EGF (Fig. 3b)
were seen to increase 3.32-fold with respect to those in non-stimulated cells (Figs. 3a and
3i). Consistently, pAkt levels were drastically reduced to control levels when EGF signaling
was inhibited by Tarceva (Figs. 3c and 3i), as well as when PI3K signaling was inhibited by
Wortmannin (Figs. 3d and 3i). Levels of phosphorylated ERK-1/2 (pERK) in cells
stimulated with EGF (Fig. 3f) increased 1.81-fold with respect to non-stimulated cells (Figs.
3e and 3j), and were similar to levels for which EGF signaling was inhibited by Tarceva
(Figs. 3g and 3j). In cells treated with Wortmannin, pERK levels were similar to those
measured in the absence of the PI3K inhibitor (Figs. 3h and 3j), indicating negligible cross-
talk between MAPK/ERK and PI3K/Akt pathways.
MB Morphology and Proliferation Within μLane System
The μLane system was next used to examine the EGF-stimulated behavior of MB-derived
cells within ECM. MB cultured within ECM-alone and ECM supplemented with 10, 100,
and 1000 ng/mL EGF were seen to grow, divide, and survive inside of the microchannel for
100 h. Cellular changes were measured via the CSI, number of cytoplasmic extensions per
cell, and observed proliferation time within the microsystem. Cells within ECM-alone
exhibited rounder morphology (Fig. 4a), while cells in ECM exposed to EGF exhibited
elongated morphology (Fig. 4b). The average, measured CSI was lower for cells exposed to
EGF (Fig. 4c), consistent with CSI definition, which approaches 1 for an amoeboidal cell
and decreases towards zero for an elongated or branched cell (Eq. 2). We note that the CSI
of MB cells remained statistically insignificant when treated with EGF-R inhibitors.
Similarly, the average number of cellular extensions was not statistically different between
stimulated and non-stimulated cells (Fig. 4d). Lastly, MB cell division was seen to occur
consistently between 42 and 46 h in all microchannel experiments. As a result, analysis of
cell behavior prior to t = 40 h was deemed to be primarily migratory and non-proliferative,
while MB behavior post t = 40 h was considered both migratory and proliferative in all
subsequent analyses.
EGF Concentration Profiles Generated Within μLane System
EGF transport within the μLane generated a range of concentrations and gradients along the
microchannel length over time. The concentration gradients present along the μLane from t
= 0 h to t = 72 h were calculated by measuring the change in EGF concentration over a fixed
microchannel distance. Mathematically, gradients can be represented by the changing slope
of the curves. Note that because EGF is distributed non-linearly along the microchannel
length prior to steady-state (as shown in Fig. 1c), concentration gradients are also highly
non-linear during this time, and encompass several orders of magnitude per experimental
condition. Steady-state EGF distributions along the microchannel generated by using
separate solutions of 10, 100, and 1000 ng/mL concentrations in the source chamber each
exhibited linear steady-state concentration gradients at t = 70 h.
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EGF-Mediated Chemotaxis of MB Within μLane System
The migration of MB-derived cells was then measured in response to the separate EGF
concentration profiles described above. Microenvironments generated by using 1000 ng/mL
in the sink chamber attracted the largest numbers of cells to migrate into the microchannel,
both prior to and after MB proliferation (i.e., before and after t = 40 h, respectively). As
shown in Fig. 5a, the numbers of cells that migrated out of the sink chamber and into the
microchannel prior to 40 h (non-proliferative) increased when exposed to increasing EGF
concentrations and gradients. Numbers of cells observed within microchannels between t =
42 h and t = 72 h (motile and proliferative) similarly increased with EGF concentration and
gradient, although in larger proportions than in experiments measuring migration alone.
Large numbers of cells were drawn into the channel when exposed to concentration
gradients generated by using 10, 100, and 1000 ng/mL concentrations. In addition, the
migration of MB treated with the inhibitors Tarceva and Wortmannin was examined within
the μLane environment generated using 1000 ng/mL EGF. As seen, the numbers of cells that
responded to EGF when EGF-R signaling was inhibited by Tarceva, and when the PI3K
pathway was inhibited by Wortmannin, were less than 5% of the controls in each case (Fig.
5a).
Additionally, the average cell distances traveled within the different environments of the
μLane were calculated for pre-proliferative cells (t < 40 h) and for cells undergoing both
migration and proliferation (t = 40 h and t = 72 h). As seen in Fig. 5b, the average cell
distances traveled prior to t = 40 h (i.e., migration only) and between t = 40 h and t = 72 h
(migration and proliferation) were lowest for controls, and increased slightly with EGF
concentration and gradient. However, no statistical difference was measured between the
different EGF concentrations.
Lastly, the average EGF concentration and concentration gradient experienced by MB cells
that became motile over the experimental time was calculated using the mathematically-
derived EGF distribution within the μLane system described in Fig. 1. As mathematically
predicted by Fick’s Law, both the absolute gradient and absolute EGF concentration present
in the channel changed with time depending upon the initial EGF condition used (i.e., 10,
100, and 1000 ng/mL).
During all experiments, MB cells were observed to become motile at early time points,
within microenvironments where cells were exposed to the highest EGF gradients and
highest EGF concentrations. Cells then appeared to become non-motile at later times, when
exposed to microenvironments with low EGF concentration and low EGF gradient. For all
experiments, changes in cell displacement within the channel were observed to approach
zero when exposed to EGF concentrations that were below ~0.85 of the initial EGF
concentration used. Similarly, in all experiments, cells became immobile when experiencing
an average decrease in relative concentration gradient of one order of magnitude between
the experimentally-measured time of t = 1 h, and the final pre-proliferation time of t = 40 h.
The average concentration experienced by motile cells between t = 1 h and t = 40 h within
our experiments that used initial 10 ng/mL concentration of EGF to generate EGF gradients
within the microchannel was ~9.0 ng/mL. Similarly, the average concentration experienced
by cells that became motile when exposed to concentration gradients generated by initial
EGF concentrations of 100 ng/mL was ~90 ng/mL. Lastly, cells exposed to concentration
gradients within the microchannel generated by initially using 1000 ng/ml of EGF
experienced an average concentration of ~900 ng/mL. In addition, motile cells experienced a
great range of concentration gradients during the transient evolution of the EGF profile
within the microchannel. Cells that became motile when exposed to concentration gradients
generated by using EGF of 10 ng/mL experienced an average concentration gradient of ~1
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ng/mL per mm of microchannel. Similarly, motile cells exposed to EGF profiles created
using 100 ng/L of EGF experienced an average concentration gradient of ~10 ng/mL per
mm of microchannel, while motile cells within EGF profiles generated using 1000 ng/mL in
our experiments experienced an average concentration gradient of ~100 ng/mL per mm.
DISCUSSION
The migration of cells from pediatric brain tumors has been largely understudied despite
their high tumor metastatic potential and aggressive invasion into healthy brain. While EGF-
R is known to play significant roles in the chemotaxis of tumor cells within adult brain, the
EGF-induced migration of MB has only recently been examined. The current study
examined the activation of EGF-R-mediated pathways in MB and directly correlated MB
migratory response to a range of EGF concentrations and gradients generated by using a
microfluidic system.
Initial immunocytochemistry experiments demonstrated constitutively-active EGF-R
signaling in the MB cells studied. Interestingly, EGF-R response was also ligand-dependent,
as increased EGF-R phosphorylation and co-localization with endosomes was observed
upon EGF stimulation. These results confirm the findings of other studies,26 which
documented basal EGF-R expression in Daoy cells via quantitative PCR, as well as
confirmed Daoy autocrine expression of EGF and TGF-α ligands. These data illustrate that
EGF-R signaling is appreciable for MB cells even in the presence of exogenous growth
factors. The finding that EGF-R in MB can respond to external EGF despite basal EGF-R
signaling bolsters the hypothesis that exogenous EGF stimulation is able to stimulate
chemotactic responses in MB-derived cells. When examining EGF activation of the PI3K
and MAPK pathways, our data illustrated that the PI3K pathway was activated by EGF and
inactivated when EGF signaling was inhibited by Tarceva, a kinase inhibitor, and
Wortmannin, an Akt inhibitor. However, our data illustrated minimal effect of either
compound on pERK, suggesting MAPK is only minimally involved in the EGF-R-induced
chemotactic signaling of these cells. This result is in conflict with existing research, which
illustrated decreased pERK activation in response to the kinase inhibitor, gefitinib, in both
serum starved and serum treated Daoy cells.5,29 However, we note that the lack of inhibited
pERK seen in our study could be due to a weaker sensitivity to Tarceva vs. gefitinib in Daoy
cells, as the gefitinib kinase inhibitor specifically targets ErbB2, which is known to be less
expressed in Daoy than other MB cell lines.26
We next examined EGF-mediated migration of MB in a microfluidic system, which enables
precise control of the cellular microenvironment, as well as real-time cell visualization and
measurement of cell behavior. While conventional systems such as transwell assays provide
quantitative data to describe numbers of cells that become motile in response to a stimulus,
the application of microdevices enables experiments to examine mechanistic parameters
such as motility, polarization, directionality or the sensitivities of individual cells to
concentration gradients and thresholds. However, we reiterate here that because our
experiments were conducted continuously for over 72 h, measurements of traveled cell
distances include effects from all transient, non-linear gradients generated during the
temporal evolution of each steady-state gradient examined (as shown in Figs. 1c and 1d). As
a result, the data includes transient effects of higher concentrations and higher gradients
present prior to steady-state at t = 70 h.
A first technical point of interest in this work is that Matrigel provided a suitable ECM for
which to evaluate MB chemotactic migration. This is of interest because the diversity of
motility modes utilized by cancer cells39 has called into question the use of Matrigel given
the matrix’s constituent, biologically-relevant molecules (reviewed in Yuan et al.42). Our
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data illustrate that the Matrigel effects were consistent with each experiment and every EGF
concentration used, and thus did not contribute to the differences in migratory measurements
recorded. In controls, a small, but measurable, number of cells were observed to migrate into
the microchannel as a likely result of MB chemokinesis. But the number of cells that
responded in our system as a result of experimental conditions greatly outweighed the
presumably-constant, baseline number of cells that migrated into the system as a result of
the Matrigel alone.
Migration experiments in our microdevice revealed that the numbers of motile cells
increased with increasing EGF concentration, both before and after proliferation occurred
within microchannels. Results of other studies from our lab, as well as from others, have
shown behaviors of cell populations that migrate preferentially in low concentration gradient
fields and high concentration,1 or high concentration gradient fields and low
concentration.21,27 Our current work illustrates that MB cells migrate preferentially in high
concentration gradient fields accompanied by high concentration. Interestingly, the distance
traveled within the microchannels was not statistically significant between the experiments
that utilized exogenous EGF, although the average cell distance traveled when exposed to
any examined amount of EGF was statistically higher than that of the control. Here, we
observed that lower concentration gradient fields correlated with lower motilities: As cells
migrated in the microchannel they experienced diminishing concentration gradients until
cell motility approached zero. We posit that MB migrated in larger numbers into the channel
when stimulated by increased concentration because a higher concentration threshold is
needed to overcome the constitutively active EGF signaling in MB. Further, since the
distance traveled by these cells was statistically insignificant, we propose that higher EGF
concentration works to stimulate a higher fraction of motile cells to invade the channel, but
that it is the change in relative concentration gradient that then determines the migration
rate.
These results are significant because similar in vitro experiments have illustrated that
gradient chemosensitivity is cell type dependent. Our data becomes among the first to
illustrate that the motility of MB-derived cells increases in larger concentration gradient
fields, not only in response to higher EGF concentration.
CONCLUSION
The current report demonstrates the role of EGF-induced Akt activation in the migration of
MB-derived cells in vitro. Results of microfluidic-based experiments correlated MB
increased chemotactic response with gradient fields, providing impetus for the development
of new anti-migratory strategies as therapeutic agents.
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Characterization of the μLane system for molecular transport. (a) Image and (b) schematics
of the μLane system. (c) Measurement of Dextran concentration profiles within a 7-mm-
long microchannel over time. The Dextran fluorescence (arbitrary units) decay with time is
plotted against the length of the microchannel (●, t = 16 min; □, t = 3 h; ■, t = 14 h; ○, t =
70 h; ▴, t = 111 h). The concentration profiles reaches a linear, steady-state at t = 70 h. (d)
Computational simulation of Dextran concentration profiles formed within the
microchannel. Computationally-derived changes in Dextran concentration within the
channel over time are plotted against the length of the microchannel (●, t = 16 min; □, t = 3
h; ■, t = 14 h; ○, t = 70 h; ▴, t = 111 h). (e) Finite Element Modeling of Dextran
concentration profiles generated within the microchannel and in the source and sink
chambers, respectively.
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EGF-R phosphorylation levels and localization are mediated by EGF pathway stimulation
and inhibition in MB-derived cells. Localization of total EGF-R (iEGF-R) in non-stimulated
cells (a), in cells stimulated with 1000 ng/mL EGF (b) and in cells in which EGF signaling
was inhibited by 1 μM Tarceva (c). (d) Levels of iEGF-R are not changed due to activation/
inactivation of the EGF pathway. Localization of phosphorylated EGF-R (pEGF-R) in non-
stimulated cells (e), in cells stimulated with 1000 ng/mL EGF (f) and in cells in which EGF
signaling was inhibited by 1 μM Tarceva (g). (h) Levels of pEGF-R are significantly
increased due to activation of the EGF pathway. (i) iEGF-R (green) (i1) accumulates in
Transferrin (Tf)-positive vesicles (purple) (i2) in EGF-stimulated cells; merged channels
(i3). Insert shows higher magnification of the boxed area and co-localization between iEGF-
R and Tf. (j) Co-localization between iEGF-R and Tf-positive vesicles, and between iEGF-R
and CT-B-positive vesicles in EGF-stimulated cells. Scale bars, 20 μm. * p < 0.05.
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Akt phosphorylation levels and localizations are mediated by EGF pathway stimulation and
inhibition in MB-derived cells. Localization of phosphorylated Akt (pAkt) in non-stimulated
cells (a), in cells stimulated with 1000 ng/mL EGF (b) cells in which EGF signaling was
inhibited by 1 μM Tarceva (c), and cells in which PI3K signaling was inhibited by 0.5 μM
Wortmannin (d). Localization of phosphorylated pERK in non-stimulated cells (e), in cells
stimulated with 1000 ng/mL EGF (F), cells in which EGF signaling was inhibited by 1 μM
Tarceva (g), and cells in which PI3K signaling was inhibited by Wortmannin (h). Scale bars,
20 μm. Quantification of pAkt (i) and pERK (j) in non-stimulated cells, cells stimulated with
EGF, cells in which EGF signaling was inhibited with Tarceva and cells in which PI3K
signaling was inhibited with Wortmannin. * p < 0.05.
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EGF induces morphological changes in MB-derived cells. (a) Cells grow and divide within
3D matrix inside of the microchannel in the absence of EGF. Arrowheads point to the
dividing cells and the resulting daughter cells. (b) Cells in the presence of 100 ng/mL EGF
within 3D matrix inside of the microchannel. Arrowheads point to the dividing cells and the
resulting daughter cells. Scale bars, 50 μm. (c) Cellular Shape Index (CSI) of cells grown
within 3D matrix in microchannels in the absence of EGF and in the presence of 100 ng/mL
EGF (sample size: n = 37, nEGF = 21). * p < 0.05. (d) Number of cellular extensions in the
absence of EGF and in the presence of 100 ng/mL EGF (sample size: n = 37, nEGF = 21).
Scale bars, 50 μm.
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Increasing EGF concentration profiles target the invasion of a large number of MB-derived
cells, and this migration is modulated by PI3K. MB-derived cells were exposed to 0, 10,
100, and 1000 ng/mL EGF concentration gradients for 72 h. Additionally, MB-derived cells
treated separately with 1 μM EGF-R inhibitor Tarceva, and 0.5 μM PI3K inhibitor
Wortmannin were exposed to 1000 ng/ml EGF concentration gradients for 72 h. (a) Number
of invading cells is dependent on the activation of EGF downstream pathway. The average
numbers of invading cells are represented with standard error bars (sample size: n0 = 7, n10
= 6, n100 = 5, n1000 = 8, nTarc = 5, nWort = 3). * p < 0.05. (b) Distance invaded by MB-
derived cells is dependent on the activation of EGF downstream pathway. The average
distances invaded into the microchannel are represented with standard error bars (sample
size: n0 = 6, n10 = 6, n100 = 4, n1000 = 7, nTarc = 4, nWort = 3). * p < 0.01. The number of
cells as well as distances migrated are represented for both 0–40 h interval (migration only
—black), as well as for the 40–72 h interval (migration and proliferation—grey).
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